Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-18 Sale |
2025-03-19 4:03 pm |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
3,535 | $1.483 | $5,242 | 481,710 (Direct) |
View |
| 2025-03-18 Sale |
2025-03-19 4:02 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
2,433 | $1.487 | $3,618 | 370,326 (Direct) |
View |
| 2025-03-18 Sale |
2025-03-19 4:02 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
13,047 | $1.504 | $19,623 | 1,571,962 (Direct) |
View |
| 2025-02-19 Sale |
2025-02-20 4:50 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
239 | $1.868 | $446 | 159,759 (Direct) |
View |
| 2025-02-19 Sale |
2025-02-20 4:50 pm |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
11 | $1.86 | $20 | 240,671 (Direct) |
View |
| 2025-01-17 Sale |
2025-01-21 4:38 pm |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
9 | $2.265 | $20 | 240,682 (Direct) |
View |
| 2025-01-17 Sale |
2025-01-21 4:37 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
123 | $2.26 | $278 | 159,998 (Direct) |
View |
| 2024-12-17 Sale |
2024-12-18 4:14 pm |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
3,245 | $2.424 | $7,866 | 240,691 (Direct) |
View |
| 2024-12-17 Sale |
2024-12-18 4:13 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
2,234 | $2.429 | $5,426 | 160,121 (Direct) |
View |
| 2024-12-17 Sale |
2024-12-18 4:12 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
12,447 | $2.466 | $30,694 | 739,819 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-20 4:10 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
197 | $2.165 | $427 | 162,355 (Direct) |
View |
| 2024-10-17 Sale |
2024-10-18 4:08 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
107 | $2.119 | $227 | 162,552 (Direct) |
View |
| 2024-09-17 Sale |
2024-09-18 4:12 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
14,550 | $1.796 | $26,132 | 752,266 (Direct) |
View |
| 2024-09-17 Sale |
2024-09-18 4:11 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
2,608 | $1.783 | $4,650 | 162,659 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 4:03 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
211 | $1.946 | $411 | 165,267 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:30 am |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
108 | $2.587 | $279 | 165,478 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:29 am |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
917 | $2.599 | $2,383 | 272,862 (Direct) |
View |
| 2024-06-18 Sale |
2024-06-20 4:20 pm |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
3,285 | $2.867 | $9,418 | 273,779 (Direct) |
View |
| 2024-06-18 Sale |
2024-06-20 4:16 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
2,540 | $2.856 | $7,254 | 165,586 (Direct) |
View |
| 2024-05-17 Sale |
2024-05-20 4:14 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
192 | $2.483 | $477 | 168,126 (Direct) |
View |
| 2023-09-20 Sale |
2023-09-21 5:06 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
742 | $1.245 | $924 | 68,318 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Option Award |
2025-04-02 4:19 pm |
N/A 2035-04-01 |
Esperion Therapeutics Inc. | ESPR | Hoffman Robert E. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2025-03-14 Option Award |
2025-03-17 5:17 pm |
N/A 2035-03-14 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
1,593,000 | $0 | 2,338,009 (Direct) |
View |
| 2025-03-14 Option Award |
2025-03-17 5:16 pm |
N/A 2035-03-14 |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
451,000 | $0 | 698,245 (Direct) |
View |
| 2025-03-14 Option Award |
2025-03-17 5:16 pm |
N/A 2035-03-14 |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
404,000 | $0 | 563,759 (Direct) |
View |
| 2025-03-14 Option Award |
2025-03-17 5:15 pm |
N/A 2035-03-14 |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
425,000 | $0 | 608,663 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:18 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director |
55,500 | $0 | 97,150 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:18 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | Fischer Seth H. Z. Director |
55,500 | $0 | 60,650 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:17 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director |
55,500 | $0 | 85,904 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:16 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | GOTTO ANTONIO M JR MD D PHIL Director |
55,500 | $0 | 84,099 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:15 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director |
55,500 | $0 | 68,761 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:14 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | Shepard Jay Director |
55,500 | $0 | 84,099 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:13 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | VITULLO NICOLE Director |
65,000 | $0 | 65,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:13 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | Woody Tracy M Director |
65,000 | $0 | 65,000 (Direct) |
View |
| 2024-03-14 Option Award |
2024-03-15 4:35 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
250,000 | $0 | 318,318 (Direct) |
View |
| 2024-03-14 Option Award |
2024-03-15 4:34 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
350,000 | $0 | 477,064 (Direct) |
View |
| 2024-03-14 Option Award |
2024-03-15 4:33 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
250,000 | $0 | 333,663 (Direct) |
View |
| 2024-03-14 Option Award |
2024-03-15 4:32 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
370,000 | $0 | 443,936 (Direct) |
View |
| 2024-03-14 Option Award |
2024-03-15 4:30 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
1,096,000 | $0 | 1,408,816 (Direct) |
View |